Condition
Stage II Cervical Cancer
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
60.0%-27% vs avg
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
60.0%
-26.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
60% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 3 (1)
Trial Status
Completed3
Terminated2
Trial Success Rate
60.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03198286Not ApplicableCompleted
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
NCT05025748Not ApplicableCompleted
Ask Questions (ASQ):Implementation of a Communication Intervention
NCT01992861Terminated
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
NCT02880007Phase 2Completed
Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer
NCT01363466Phase 3Terminated
Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer
Showing all 5 trials